does tirzepatide cause vision changes Comparative ocular outcomes of versus other anti-obesity medications in people with obesity How Do You Feel on

Women with PCOS face a 2.8-fold higher risk for obesity and a 1.7-fold higher risk for central obesity compared with individuals without PCOS ( AOMs, including liraglutide and semaglutide, combined with lifestyle intervention could offer an upgraded treatment strategy for patients with PCOS and obesity ( Even though GLP-1 RAs seem to have a great potential to improve obesity-related metabolic and reproductive complications in PCOS, their use is currently not widely acknowledged and accepted in this population

Many people have actual or functional hypothyroidism by the time they are diagnosed with Hashis

In 11 cases (50%) there were pre-existing major pathologies (such as schizophrenia, migraine, obesity, hypertension, substance abuse)

Compounded GLP-1 medications dont work the same for every woman especially during perimenopause or menopause, when your hormones are shifting